A detailed history of Mv Capital Management, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Mv Capital Management, Inc. holds 140 shares of DXCM stock, worth $11,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Previous 276 49.28%
Holding current value
$11,205
Previous $31,000 70.97%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $8,704 - $15,784
-136 Reduced 49.28%
140 $9,000
Q2 2024

Aug 01, 2024

SELL
$110.31 - $140.45 $551 - $702
-5 Reduced 1.78%
276 $31,000
Q1 2024

Apr 18, 2024

BUY
$114.22 - $140.1 $456 - $560
4 Added 1.44%
281 $38,000
Q4 2023

Jan 29, 2024

BUY
$75.49 - $124.16 $10,417 - $17,134
138 Added 99.28%
277 $34,000
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $7,229 - $11,586
-84 Reduced 37.67%
139 $12,000
Q2 2023

Aug 03, 2023

BUY
$112.47 - $130.98 $2,249 - $2,619
20 Added 9.85%
223 $28,000
Q1 2023

Apr 26, 2023

BUY
$104.0 - $122.92 $3,432 - $4,056
33 Added 19.41%
203 $23,000
Q4 2022

Jan 27, 2023

BUY
$84.98 - $122.67 $1,954 - $2,821
23 Added 15.65%
170 $0
Q3 2022

Oct 24, 2022

BUY
$76.35 - $94.18 $4,199 - $5,179
55 Added 59.78%
147 $12,000
Q2 2022

Jul 19, 2022

BUY
$67.99 - $132.89 $2,243 - $4,385
33 Added 55.93%
92 $7,000
Q1 2022

May 09, 2022

BUY
$94.08 - $130.2 $2,352 - $3,254
25 Added 73.53%
59 $30,000
Q4 2021

Feb 02, 2022

BUY
$129.87 - $162.82 $519 - $651
4 Added 13.33%
34 $18,000
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $1,280 - $1,718
12 Added 66.67%
30 $16,000
Q2 2021

Aug 03, 2021

BUY
$80.99 - $107.93 $1,214 - $1,618
15 Added 500.0%
18 $8,000
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $254 - $314
3 New
3 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.